Cargando…

Symptomatic venous thromboembolism following a hip fracture: Incidence and risk factors in 5,300 patients

Background and purpose Venous thromboembolism (VTE) remains a substantial cause of morbidity and mortality following hip fracture. Previous work has not identified any risk factors associated with the type of hip fracture. We report the incidence of and risk factors for development of symptomatic VT...

Descripción completa

Detalles Bibliográficos
Autores principales: McNamara, Iain, Sharma, Aman, Prevost, Teresa, Parker, Martyn
Formato: Texto
Lenguaje:English
Publicado: Informa Healthcare 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823318/
https://www.ncbi.nlm.nih.gov/pubmed/19968601
http://dx.doi.org/10.3109/17453670903448273
_version_ 1782177631695798272
author McNamara, Iain
Sharma, Aman
Prevost, Teresa
Parker, Martyn
author_facet McNamara, Iain
Sharma, Aman
Prevost, Teresa
Parker, Martyn
author_sort McNamara, Iain
collection PubMed
description Background and purpose Venous thromboembolism (VTE) remains a substantial cause of morbidity and mortality following hip fracture. Previous work has not identified any risk factors associated with the type of hip fracture. We report the incidence of and risk factors for development of symptomatic VTE in patients following a hip fracture. Patients and methods In this prospective study, we collected information on 5,300 consecutive patients who were admitted to a single unit with a hip fracture—in terms of their pre-admission status, details of any operation performed, and details of complications in the form of symptomatic venous thromboembolism. All patients received thromboprophylaxis with heparin. Results The incidence of symptomatic VTE was 2.2% (95% CI: 1.8–2.6). 85% of these events occurred within 5 weeks of the fracture. The statistically significant risk factors for symptomatic VTE were better preoperative mobility, living in one's own home, high mental test score, high preoperative hemoglobin, inter-trochanteric fractures, and fixation with a dynamic hip screw. In multivariate analysis adjusting for sex and age, type of residence on admission, type of fracture, and hemoglobin values on admission remained independently significant. Interpretation We found that the rate of symptomatic VTE using thromboprophylaxis with heparin was low but that there were a number of groups that were at a significantly higher risk of developing VTE. The patients who are particularly at risk appear to be those with a subtrochanteric or intertrochanteric hip fracture; here, the incidence of symptomatic VTE was twice that of intracapsular hip fractures.
format Text
id pubmed-2823318
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Informa Healthcare
record_format MEDLINE/PubMed
spelling pubmed-28233182010-02-18 Symptomatic venous thromboembolism following a hip fracture: Incidence and risk factors in 5,300 patients McNamara, Iain Sharma, Aman Prevost, Teresa Parker, Martyn Acta Orthop Research Article Background and purpose Venous thromboembolism (VTE) remains a substantial cause of morbidity and mortality following hip fracture. Previous work has not identified any risk factors associated with the type of hip fracture. We report the incidence of and risk factors for development of symptomatic VTE in patients following a hip fracture. Patients and methods In this prospective study, we collected information on 5,300 consecutive patients who were admitted to a single unit with a hip fracture—in terms of their pre-admission status, details of any operation performed, and details of complications in the form of symptomatic venous thromboembolism. All patients received thromboprophylaxis with heparin. Results The incidence of symptomatic VTE was 2.2% (95% CI: 1.8–2.6). 85% of these events occurred within 5 weeks of the fracture. The statistically significant risk factors for symptomatic VTE were better preoperative mobility, living in one's own home, high mental test score, high preoperative hemoglobin, inter-trochanteric fractures, and fixation with a dynamic hip screw. In multivariate analysis adjusting for sex and age, type of residence on admission, type of fracture, and hemoglobin values on admission remained independently significant. Interpretation We found that the rate of symptomatic VTE using thromboprophylaxis with heparin was low but that there were a number of groups that were at a significantly higher risk of developing VTE. The patients who are particularly at risk appear to be those with a subtrochanteric or intertrochanteric hip fracture; here, the incidence of symptomatic VTE was twice that of intracapsular hip fractures. Informa Healthcare 2009-12-04 2009-12-04 /pmc/articles/PMC2823318/ /pubmed/19968601 http://dx.doi.org/10.3109/17453670903448273 Text en Copyright: © Nordic Orthopedic Federation http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.
spellingShingle Research Article
McNamara, Iain
Sharma, Aman
Prevost, Teresa
Parker, Martyn
Symptomatic venous thromboembolism following a hip fracture: Incidence and risk factors in 5,300 patients
title Symptomatic venous thromboembolism following a hip fracture: Incidence and risk factors in 5,300 patients
title_full Symptomatic venous thromboembolism following a hip fracture: Incidence and risk factors in 5,300 patients
title_fullStr Symptomatic venous thromboembolism following a hip fracture: Incidence and risk factors in 5,300 patients
title_full_unstemmed Symptomatic venous thromboembolism following a hip fracture: Incidence and risk factors in 5,300 patients
title_short Symptomatic venous thromboembolism following a hip fracture: Incidence and risk factors in 5,300 patients
title_sort symptomatic venous thromboembolism following a hip fracture: incidence and risk factors in 5,300 patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823318/
https://www.ncbi.nlm.nih.gov/pubmed/19968601
http://dx.doi.org/10.3109/17453670903448273
work_keys_str_mv AT mcnamaraiain symptomaticvenousthromboembolismfollowingahipfractureincidenceandriskfactorsin5300patients
AT sharmaaman symptomaticvenousthromboembolismfollowingahipfractureincidenceandriskfactorsin5300patients
AT prevostteresa symptomaticvenousthromboembolismfollowingahipfractureincidenceandriskfactorsin5300patients
AT parkermartyn symptomaticvenousthromboembolismfollowingahipfractureincidenceandriskfactorsin5300patients